Biogipuzkoa
Centro de investigación
![Foto de Biogipuzkoa](/img/uploaded/BB680065D0326B877226AAACFBE7F51A.png)
![Foto de University of South Florida](/img/noimage_org.png)
University of South Florida
Tampa, Estados UnidosPublicaciones en colaboración con investigadores/as de University of South Florida (7)
2022
-
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
npj Parkinson's Disease, Vol. 8, Núm. 1
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2019
-
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
Parkinsonism and Related Disorders, Vol. 62, pp. 201-209
-
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
Alzheimer's and Dementia, Vol. 15, Núm. 6, pp. 817-827
2017
-
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
Oncogene, Vol. 36, Núm. 19, pp. 2737-2749
2016
-
Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy
Movement Disorders, Vol. 31, Núm. 5, pp. 742-747
2014
-
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
Movement Disorders, Vol. 29, Núm. 4, pp. 470-478